These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29190626)

  • 1. SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis.
    Hu H; Cai W; Zheng S; Ge W
    Cell Physiol Biochem; 2017; 44(4):1485-1496. PubMed ID: 29190626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers.
    Hu H; Zhang H; Ge W; Liu X; Loera S; Chu P; Chen H; Peng J; Zhou L; Yu S; Yuan Y; Zhang S; Lai L; Yen Y; Zheng S
    Clin Cancer Res; 2012 Oct; 18(19):5438-48. PubMed ID: 22891198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer.
    Zhang HP; Wu J; Liu ZF; Gao JW; Li SY
    Biomed Res Int; 2022; 2022():1398268. PubMed ID: 35111844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.
    Yu Y; Chen Y; Ma J; Yu X; Yu G; Li Z
    Tumour Biol; 2016 Mar; 37(3):4159-67. PubMed ID: 26490986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
    Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
    Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
    Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
    J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis.
    Cheng F; Zeng C; Zeng L; Chen Y
    Medicine (Baltimore); 2019 Oct; 98(40):e17310. PubMed ID: 31577724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.
    Zhang M; Dong Y; Liu H; Wang Y; Zhao S; Xuan Q; Wang Y; Zhang Q
    Sci Rep; 2016 Nov; 6():37933. PubMed ID: 27892511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPARCL1 expression increases with preoperative radiation therapy and predicts better survival in rectal cancer patients.
    Kotti A; Holmqvist A; Albertsson M; Sun XF
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1196-202. PubMed ID: 24661672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
    Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
    PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis.
    Yin S; Huang J; Li Z; Zhang J; Luo J; Lu C; Xu H; Xu H
    PLoS One; 2017; 12(1):e0170042. PubMed ID: 28081243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors.
    Shen C; Yin Y; Chen H; Wang R; Yin X; Cai Z; Zhang B; Chen Z; Zhou Z
    BMC Gastroenterol; 2018 Jul; 18(1):105. PubMed ID: 29973149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
    Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
    Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis.
    Zhu J; Xue Z; Zhang S; Guo X; Zhai L; Shang S; Zhang Y; Lu H
    Int J Surg; 2018 Sep; 57():76-83. PubMed ID: 30103072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer.
    Yu SJ; Yu JK; Ge WT; Hu HG; Yuan Y; Zheng S
    World J Gastroenterol; 2011 Apr; 17(15):2028-36. PubMed ID: 21528083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic and Clinicopathological Roles of Sirtuin-3 in Various Cancers.
    Yu FY; Xu Q; Wu DD; Lau AT; Xu YM
    PLoS One; 2016; 11(8):e0159801. PubMed ID: 27483432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of reduced SPARCL1 expression in human breast cancer.
    Cao F; Wang K; Zhu R; Hu YW; Fang WZ; Ding HZ
    Asian Pac J Cancer Prev; 2013; 14(1):195-200. PubMed ID: 23534723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
    Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
    BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.
    Lu L; Huang F; Zhao Z; Li C; Liu T; Li W; Fu W
    Medicine (Baltimore); 2016 Dec; 95(50):e5603. PubMed ID: 27977599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.